An excellent pharmacokinetic profile can actually act as a double-edged sword.
Hui
Mamie
M
D000081:Acetamides / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness; D006801:Humans; D007362:Intensive Care Units; D007413:Intestinal Mucosa / Q000187:drug effects / Q000382:microbiology; D000069349:Linezolid; D008168:Lung / Q000187:drug effects; D023303:Oxazolidinones / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D011379:Prognosis; D012121:Respiration, Artificial / Q000009:adverse effects / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
D000081:Acetamides; D023303:Oxazolidinones; D000069349:Linezolid